Bloomberg News reported this week on how world leaders can be successful in ending TB by 2030 and the demographics that TB affects most. One article discusses multi-drug and extensive drug resistant patients as well as challenges, funding needs, and the needs for new tools to defeat TB. The other discusses TB's strong link to the most impovershed populations. To read more, please click below:
Article 2: Who dies from TB?